Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001737287-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
957,770
Total Value
$63,189.00
P&L
+inf% (+$1,908,684.90)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP of R&D | Common Stock | โ | Feb 2, 2026 | Sale | 35,700 | $1.77 | $63,189.00 | 581,166 | Direct | โ | View Details | |
EVP of R&D | Stock Option (Right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 718,763 | $0.00 | $0.00 | 718,763 | Direct | โ | View Details | |
EVP of R&D | Restricted Stock Unit | Derivative | Feb 2, 2026 | Grant/Award | 203,307 | $0.00 | $0.00 | 203,307 | Direct | โ | View Details |